SKYSTAR BIO-PHARMACEUTICAL CO 4
4 · SKYSTAR BIO-PHARMACEUTICAL CO · Filed Dec 11, 2014
Insider Transaction Report
Form 4
GREGORY JOHN M
10% Owner
Transactions
- Purchase
Common Stock
2014-12-10$4.56/sh+103,016$469,753→ 313,220 total(indirect: By LLC)
Holdings
- 193,500
Common Stock
- 466,000(indirect: By Kingsway Charities, Inc.)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.37 to $4.6499 inclusive. The reporting person undertakes to provide the Issuer, any stockholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.